Exercise as part of a cystic fibrosis therapeutic routine

被引:0
|
作者
Rand, Sarah [1 ,2 ]
Prasad, S. Ammani [1 ]
机构
[1] Great Ormond St Hosp Children NHS Fdn Trust, Cyst Fibrosis Unit, London, England
[2] UCL Inst Child Hlth, Portex Unit, London, England
关键词
cystic fibrosis; exercise; exercise capacity; physiotherapy; therapeutic routine; HABITUAL PHYSICAL-ACTIVITY; BONE-MINERAL DENSITY; LUNG-FUNCTION; OXYGEN-UPTAKE; SPUTUM EXPECTORATION; CHEST PHYSIOTHERAPY; NUTRITIONAL-STATUS; MUSCLE WEAKNESS; CHILDREN; ADULTS;
D O I
10.1586/ERS.12.19
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The role of exercise in cystic fibrosis (CF) is well established, and over the last three decades it has become an important component in the management of all individuals with CF. The role of exercise as a prognostic indicator or therapeutic tool is an important area of research interest in CF care internationally. This article summarizes the currently available evidence regarding exercise capacity in CF, the potential effects of exercise on health outcomes in CF and the challenges faced when trying to incorporate exercise into a CF therapeutic routine, and highlights some methods to facilitate the incorporation of exercise into CF therapeutic routines.
引用
收藏
页码:341 / 352
页数:12
相关论文
共 50 条
  • [31] Exercise and Cystic Fibrosis (CF) 2.0
    Cerny, Frank
    PEDIATRIC EXERCISE SCIENCE, 2013, 25 (04) : 616 - 623
  • [32] Exercise recommendations for individuals with cystic fibrosis
    Boas, SR
    SPORTS MEDICINE, 1997, 24 (01) : 17 - 37
  • [33] EXERCISE TESTING IN CYSTIC-FIBROSIS
    ORENSTEIN, D
    GERMANN, K
    CLINICAL RESEARCH, 1981, 29 (05): : A902 - A902
  • [34] Update on the role of exercise in cystic fibrosis
    Orenstein, DM
    Higgins, LW
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (06) : 519 - 523
  • [35] Therapeutic potential of phytochemicals for cystic fibrosis
    Baharara, Hamed
    Kesharwani, Prashant
    Johnston, Thomas P.
    Sahebkar, AmirHossein
    BIOFACTORS, 2023, 49 (05) : 984 - 1009
  • [36] Novel Therapeutic Approaches for Cystic Fibrosis
    Wilschanski, Michael
    DISCOVERY MEDICINE, 2013, 15 (81) : 127 - 133
  • [37] PPARγ as a therapeutic target in cystic fibrosis
    Dekkers, Johanna F.
    van der Ent, Cornelis K.
    Kalkhoven, Eric
    Beekman, Jeffrey M.
    TRENDS IN MOLECULAR MEDICINE, 2012, 18 (05) : 283 - 291
  • [38] THERAPEUTIC MANAGEMENT OF CYSTIC-FIBROSIS
    KUHN, RJ
    NAHATA, MC
    CLINICAL PHARMACY, 1985, 4 (05): : 555 - 565
  • [39] New therapeutic developments in cystic fibrosis
    Bui, S.
    Macey, J.
    Fayon, M.
    Bihouee, T.
    Burgel, P. -R.
    Colomb, V.
    Corvol, H.
    Durieu, I.
    Hubert, D.
    Marguet, C.
    Mas, E.
    Munck, A.
    Murris-Espin, M.
    Reix, R.
    Sermet-Gaudelus, I.
    ARCHIVES DE PEDIATRIE, 2016, 23 : S47 - S53
  • [40] Therapeutic advances in cystic fibrosis in 2014
    Durupt, S.
    Mazur, S.
    Reix, P.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2016, 72 (01) : 77 - 86